| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |